Rating History for Par Pharmaceutical (PRX) by Piper Sandler

More Stocks Rated by Piper Sandler | Latest Ratings for PRX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/16/2012 N/A Downgrade Neutral
(Overweight)		 50.00
(N/A)		 36.58
(49.98)		 36.63% Details